BMY vs SPFI · P/E 17, rev $24.46B vs P/E 12, rev $137.6M
Bristol-Myers Squibb Company (BMY) versus South Plains Financial Inc (SPFI) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
South Plains Financial Inc (SPFI) is a banks - regional company listed on NASDAQ.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported SPFI revenue for 2026-06-30 was $137.6M. Net income was $33.5M. SPFI currently screens at market cap $792.4M and trailing P/E 11.6.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. SPFI currently screens at market cap $792.4M and trailing P/E 11.6.
Not investment advice. Open the BMY and SPFI stock pages for the full models.
Not investment advice.